I  Georgia Research Alliance

http://www.gra.org





     Office Locations:

191 Peachtree Street, NE, Suite 849
Atlanta, GA 30303
Phone: 404-332-9770

 

Stages:

  • Early


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    GRA operates as an independent not-for-profit entity governed by leaders from industry and academia. While GRA receives a state appropriation for investment in university-based research opportunities, its small staff and lean operations are funded through foundation and industry contributions. In its first 19 years, GRA leveraged $525 million in state funding into $2.6 billion of additional federal and private investment. VentureLab is GRA's signature technology commercialization program. Launched in 2002, VentureLab helps build high-growth companies around laboratory discoveries at GRA's partner universities. VentureLab seeks out university-based research innovations, evaluates their commercial potential and provides resources to address the management, market and technology risks that come with new ventures. Each participating university -- Georgia Tech, Emory, the University of Georgia, Georgia State University and Georgia Health Sciences University -- has an active technology incubator with which VentureLab can partner. In the last five years through VentureLab, GRA has evaluated the commercial potential of more than 260 university inventions or discoveries and awarded VentureLab grants to form 107 active companies. At the end of 2010, these companies employed more than 640 professionals, had attracted $460.2 million in private equity investment and generated nearly $77 million in revenue.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Amy C. Moore Ph.D. Director
    Ashley F. Cornelison Project Manager
    C. Michael Cassidy President and CEO
    Greg Dane Director
    H. Lee Herron Vice President of Commercialization

     

    Portfolio companies include:


      ArunA Biomedical
        web link


      Axion Biosystems
        web link


      Body Surface Translations
        web link


      Cardiomems
        web link


      Celtaxsys
        web link


      Clearside Biomedical
        web link


      Damballa
        web link


      Digital Vision
        web link


      Elevar
        web link


      GeoVax
        web link


      Innovolt
        web link


      InsectiGen
        web link


      MedShape Solutions
        web link


      NeurOp
        web link


      OptiRTC
        web link


      Pramana
        web link


      REACH Health
        web link


      Scintigra
        web link


      Sentrinsic
        web link


      Suniva
        web link


     

    Recent News:


      There is no recent news for Georgia Research Alliance.